136 related articles for article (PubMed ID: 21273553)
1. Soluble M6P/IGF2R released by TACE controls angiogenesis via blocking plasminogen activation.
Leksa V; Loewe R; Binder B; Schiller HB; Eckerstorfer P; Forster F; Soler-Cardona A; Ondrovicová G; Kutejová E; Steinhuber E; Breuss J; Drach J; Petzelbauer P; Binder BR; Stockinger H
Circ Res; 2011 Mar; 108(6):676-85. PubMed ID: 21273553
[TBL] [Abstract][Full Text] [Related]
2. Mannose 6-phosphate/insulin-like growth factor 2 receptor limits cell invasion by controlling alphaVbeta3 integrin expression and proteolytic processing of urokinase-type plasminogen activator receptor.
Schiller HB; Szekeres A; Binder BR; Stockinger H; Leksa V
Mol Biol Cell; 2009 Feb; 20(3):745-56. PubMed ID: 19037107
[TBL] [Abstract][Full Text] [Related]
3. Dissecting mannose 6-phosphate-insulin-like growth factor 2 receptor complexes that control activation and uptake of plasminogen in cells.
Leksa V; Pfisterer K; Ondrovičová G; Binder B; Lakatošová S; Donner C; Schiller HB; Zwirzitz A; Mrvová K; Pevala V; Kutejová E; Stockinger H
J Biol Chem; 2012 Jun; 287(27):22450-62. PubMed ID: 22613725
[TBL] [Abstract][Full Text] [Related]
4. Biotin-Chasing Assay to Evaluate uPAR Stability and Cleavage on the Surface of Cells.
Leksa V; Schiller HB; Stockinger H
Methods Mol Biol; 2018; 1731():39-47. PubMed ID: 29318541
[TBL] [Abstract][Full Text] [Related]
5. Thrombomodulin functions as a plasminogen receptor to modulate angiogenesis.
Chen PK; Chang BI; Kuo CH; Chen PS; Cho CF; Chang CF; Shi GY; Wu HL
FASEB J; 2013 Nov; 27(11):4520-31. PubMed ID: 23943648
[TBL] [Abstract][Full Text] [Related]
6. M6P/IGFII-receptor complexes urokinase receptor and plasminogen for activation of transforming growth factor-beta1.
Godár S; Horejsi V; Weidle UH; Binder BR; Hansmann C; Stockinger H
Eur J Immunol; 1999 Mar; 29(3):1004-13. PubMed ID: 10092105
[TBL] [Abstract][Full Text] [Related]
7. IGF-II/mannose 6-phosphate receptor activation induces metalloproteinase-9 matrix activity and increases plasminogen activator expression in H9c2 cardiomyoblast cells.
Chang MH; Kuo WW; Chen RJ; Lu MC; Tsai FJ; Kuo WH; Chen LY; Wu WJ; Huang CY; Chu CH
J Mol Endocrinol; 2008 Aug; 41(2):65-74. PubMed ID: 18495691
[TBL] [Abstract][Full Text] [Related]
8. Targeting of urokinase plasminogen activator receptor in human pancreatic carcinoma cells inhibits c-Met- and insulin-like growth factor-I receptor-mediated migration and invasion and orthotopic tumor growth in mice.
Bauer TW; Liu W; Fan F; Camp ER; Yang A; Somcio RJ; Bucana CD; Callahan J; Parry GC; Evans DB; Boyd DD; Mazar AP; Ellis LM
Cancer Res; 2005 Sep; 65(17):7775-81. PubMed ID: 16140945
[TBL] [Abstract][Full Text] [Related]
9. Binding of urokinase-type plasminogen activator receptor (uPAR) to the mannose 6-phosphate/insulin-like growth factor II receptor: contrasting interactions of full-length and soluble forms of uPAR.
Kreiling JL; Byrd JC; Deisz RJ; Mizukami IF; Todd RF; MacDonald RG
J Biol Chem; 2003 Jun; 278(23):20628-37. PubMed ID: 12665524
[TBL] [Abstract][Full Text] [Related]
10. Direct interaction of the kringle domain of urokinase-type plasminogen activator (uPA) and integrin alpha v beta 3 induces signal transduction and enhances plasminogen activation.
Tarui T; Akakura N; Majumdar M; Andronicos N; Takagi J; Mazar AP; Bdeir K; Kuo A; Yarovoi SV; Cines DB; Takada Y
Thromb Haemost; 2006 Mar; 95(3):524-34. PubMed ID: 16525582
[TBL] [Abstract][Full Text] [Related]
11. uPA/uPAR downregulation inhibits radiation-induced migration, invasion and angiogenesis in IOMM-Lee meningioma cells and decreases tumor growth in vivo.
Kargiotis O; Chetty C; Gogineni V; Gondi CS; Pulukuri SM; Kyritsis AP; Gujrati M; Klopfenstein JD; Dinh DH; Rao JS
Int J Oncol; 2008 Nov; 33(5):937-47. PubMed ID: 18949356
[TBL] [Abstract][Full Text] [Related]
12. Human endothelial cell migration is stimulated by urokinase plasminogen activator:plasminogen activator inhibitor 1 complex released from endometrial stromal cells stimulated with transforming growth factor beta1; possible mechanism for paracrine stimulation of endometrial angiogenesis.
Sandberg T; Casslén B; Gustavsson B; Benraad TJ
Biol Reprod; 1998 Oct; 59(4):759-67. PubMed ID: 9746723
[TBL] [Abstract][Full Text] [Related]
13. siRNA-mediated simultaneous downregulation of uPA and its receptor inhibits angiogenesis and invasiveness triggering apoptosis in breast cancer cells.
Subramanian R; Gondi CS; Lakka SS; Jutla A; Rao JS
Int J Oncol; 2006 Apr; 28(4):831-9. PubMed ID: 16525631
[TBL] [Abstract][Full Text] [Related]
14. Cyclo19,31[D-Cys19]-uPA19-31 is a potent competitive antagonist of the interaction of urokinase-type plasminogen activator with its receptor (CD87).
Magdolen V; Bürgle M; de Prada NA; Schmiedeberg N; Riemer C; Schroeck F; Kellermann J; Degitz K; Wilhelm OG; Schmitt M; Kessler H
Biol Chem; 2001 Aug; 382(8):1197-205. PubMed ID: 11592401
[TBL] [Abstract][Full Text] [Related]
15. Urokinase type plasminogen activator receptor is involved in insulin-like growth factor-induced migration of rhabdomyosarcoma cells in vitro.
Gallicchio MA; Kaun C; Wojta J; Binder B; Bach LA
J Cell Physiol; 2003 Oct; 197(1):131-8. PubMed ID: 12942549
[TBL] [Abstract][Full Text] [Related]
16. High urokinase expression contributes to the angiogenic properties of endothelial cells derived from circulating progenitors.
Basire A; Sabatier F; Ravet S; Lamy E; Mialhe A; Zabouo G; Paul P; Gurewich V; Sampol J; Dignat-George F
Thromb Haemost; 2006 Apr; 95(4):678-88. PubMed ID: 16601839
[TBL] [Abstract][Full Text] [Related]
17. Urokinase induces survival or pro-apoptotic signals in human mesangial cells depending on the apoptotic stimulus.
Tkachuk N; Kiyan J; Tkachuk S; Kiyan R; Shushakova N; Haller H; Dumler I
Biochem J; 2008 Oct; 415(2):265-73. PubMed ID: 18564064
[TBL] [Abstract][Full Text] [Related]
18. Endostatin-induced modulation of plasminogen activation with concomitant loss of focal adhesions and actin stress fibers in cultured human endothelial cells.
Wickström SA; Veikkola T; Rehn M; Pihlajaniemi T; Alitalo K; Keski-Oja J
Cancer Res; 2001 Sep; 61(17):6511-6. PubMed ID: 11522648
[TBL] [Abstract][Full Text] [Related]
19. uPA and uPAR shRNA inhibit angiogenesis via enhanced secretion of SVEGFR1 independent of GM-CSF but dependent on TIMP-1 in endothelial and glioblastoma cells.
Raghu H; Nalla AK; Gondi CS; Gujrati M; Dinh DH; Rao JS
Mol Oncol; 2012 Feb; 6(1):33-47. PubMed ID: 22177802
[TBL] [Abstract][Full Text] [Related]
20. Mannose 6-phosphate/insulin-like growth factor II receptor mediates the growth-inhibitory effects of retinoids.
Kang JX; Bell J; Beard RL; Chandraratna RA
Cell Growth Differ; 1999 Aug; 10(8):591-600. PubMed ID: 10470859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
